Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05265520 · ClinicalTrials.gov registry record · NA

His-Bundle Corrective Pacing in Heart Failure

A NA study of Heart Failure and Cardiac Resynchronization Therapy, sponsored by University of Rochester.

Recruiting
Registry status
NA
Development phase
120
Enrollment target
14
Study locations

NCT05265520 is a NA study of Heart Failure and Cardiac Resynchronization Therapy that is actively recruiting participants, run by University of Rochester. The registered enrollment target is 120 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The trial reports 14 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05265520, a NA study of Heart Failure and Cardiac Resynchronization Therapy, is actively recruiting participants, sponsored by University of Rochester.

RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
14
Study locations

Study Summary

The investigators aim to prospectively evaluate the efficacy and mechanism of benefit of His-bundle pacing enhanced cardiac resynchronization therapy (His-CRT) vs. cardiac resynchronization therapy (BIV-CRT) in patients with heart failure and right bundle branch block (RBBB).

Conditions Studied

Heart Failure Cardiac Resynchronization Therapy Right Bundle-Branch Block His-bundle Pacing

Interventions

  • PROCEDURE His-CRT implantation
  • PROCEDURE BIV-CRT implantation

Study Locations (14)

Illinois

  • Northwestern Memorial Hospital - Chicago
  • Rush University Medical Center - Chicago
  • University of Chicago - Chicago

New York

  • Weill Cornell Medical College - New York
  • Mount Sinai Hospital - New York

Pennsylvania

  • University of Pennsylvania - Philadelphia
  • Geisinger Wyoming Valley - Wilkes-Barre

Arizona

  • University of Arizona - Phoenix

California

  • Cedars-Sinai Medical Center - Los Angeles

Florida

  • University of South Florida - Tampa

New Jersey

  • Valley Health System - Ridgewood

North Carolina

  • Mission Health - Asheville

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-12-02
Est. Completion 2028-07-01
Phase NA

Sponsor

University of Rochester

636 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05265520

The ClinicalTrials.gov registry entry for NCT05265520 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (94% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which His-CRT implantation is the first listed.

NCT05265520 reports 14 study locations spanning 10 distinct geographic areas - top geographies include Illinois, New York, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05265520 about?

NCT05265520 is a clinical study titled "His-Bundle Corrective Pacing in Heart Failure". The investigators aim to prospectively evaluate the efficacy and mechanism of benefit of His-bundle pacing enhanced cardiac resynchronization therapy (His-CRT) vs. cardiac resynchronization therapy (BIV-CRT) in patients with heart failure and right bundle branch block (RBBB).

What is the current status of trial NCT05265520?

This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-12-02. Estimated completion is 2028-07-01.

What conditions does trial NCT05265520 study?

This clinical trial studies the following conditions: Heart Failure, Cardiac Resynchronization Therapy, Right Bundle-Branch Block, His-bundle Pacing.

What interventions are being tested in trial NCT05265520?

The interventions under investigation include: His-CRT implantation (PROCEDURE), BIV-CRT implantation (PROCEDURE).

Who is sponsoring clinical trial NCT05265520?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05265520 being conducted?

This trial has 14 study locations across Arizona, California, Florida, Illinois, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Heart Failure

All registered trials for this condition

Cardiac Resynchronization Therapy

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.